OTC policy requires that OTC hold copyright to all copyrightable material in its publications, including conference proceedings, and to the individual contributions contained therein, to protect the interests of OTC, authors and their employers, and at the same time, to facilitate the appropriate re-use of this material by others.
OTC distributes its publications throughout the world and does so by various print and electronic means. OTC also may translate or authorize translation of its publications, and articles contained therein, for inclusion in various publications.
Transfer of copyright to OTC is a requirement for publication, including publication in conference proceedings, with the exception of material that is in the public domain (i.e., is not subject to copyright). Publications are critical in OTC’s mission.
OTC needs to hold copyright to the material. This process allows for maximum dissemination of the information while maximizing protection against infringement by third parties.
Providing copyright to OTC does not mean that the author and his or her employer lose all rights to the material. The author/employer retains any and all rights to any proprietary material disclosed in the paper. Authors and their employers also retain certain rights to make copies and reuse the material (see below).
Under the terms of U.S. copyright law, an assignment of copyright must be a written, signed document from the owner of the work. Copyright assignment protects reproduction and distribution of the paper. OTC does not accept limited permissions, including special licenses, to publish. A Transfer of Copyright Form (wording varies for some jointly-sponsored meetings) must accompany and be executed for any original material to be published by OTC, including publication in conference proceedings. To ensure uniform treatment among all contributors, other forms may not be substituted for this form, nor may any wording of the form be changed.